image credit: wikimedia

Drugmaker Gilead reaches agreement with White House to donate HIV prevention med

May 10, 2019


Pharmaceutical giant Gilead Sciences has agreed to donate drugs that reduce the risk of HIV transmission for up to 200,000 people a year, the Trump administration says.

The agreement between Gilead and the Trump administration will last until at least Dec. 31, 2025, and possibly through the end of 2030, Health and Human Services Secretary Alex Azar said in a statement Thursday. Gilead will donate its PrEP medication Truvada, which is used to reduce the risk of HIV infection and usually sells for $1,600 to $2,000 a month in the United States.

Read More on CNBC